{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-028904","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2023-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.894849+00:00","generated_at":"2026-06-09T09:37:38.660715+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BIO-key Q3 revenue up 33% to $1.8M, net loss per share narrows to ($0.08) from ($0.29)","bullets":["Revenue $1.8M (+33% YoY); gross profit $1.4M (+43%); gross margin 77% vs 71%.","Operating loss improved to ~$750K from $2.4M; net loss per share ($0.08) vs ($0.29) in Q3'22.","Nine-month revenue $6.8M (+30%); net loss reduced to $2.5M from $5.1M in year-ago period.","ARR ~$7M; secured additional order from international defense ministry customer for expanded rollout.","Cash and equivalents $0.3M; seeking expense reductions including HQ relocation to reach breakeven."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-028904","json":"https://secwatch.observer/filing/0001437749-23-028904.json","markdown":"https://secwatch.observer/filing/0001437749-23-028904.md","text":"https://secwatch.observer/filing/0001437749-23-028904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/0001437749-23-028904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/bkyi20231024_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T09:37:38.660715+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a89c86cc52b29bf886393f32cdbeb92877cfff83","claim":"BIO KEY INTERNATIONAL INC reported three and nine months ended September 30, 2023 results: revenue $1.8M, EPS ($0.08).","evidence_excerpt":"(EXHIBIT 99.1) --- EX-99.1 2 ex_585492.htm EXHIBIT 99.1 ex_585492.htm Exhibit 99.1 Digital Authentication and Identity Provider BIO-key Sees Q3 Revenues Rising over 30% to $1.8M on Strength in Software License Fees, Services and Hardware Sales Holmdel, NJ – October 25, 2023 - BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923028904/0001437749-23-028904-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2023"},{"label":"Revenue","value":"$1.8M"},{"label":"EPS","value":"($0.08)"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}